Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Point Of Care (POC) Immunoassay Analyzer Expansion Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The point of care (POC) immunoassay analyzer expansion market size has experienced robust growth in recent years. This market is projected to expand from $4.9 billion in 2025 to $5.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. Historically, this growth has been fueled by factors such as the rising prevalence of infectious diseases, the expansion of hospital laboratory infrastructure, the increasing demand for rapid diagnostics, broader adoption of immunoassay technology, and advancements in antibody and antigen detection methods.
The point of care (POC) immunoassay analyzer expansion market is projected to experience substantial growth in the upcoming years. This market is anticipated to reach $7.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.8%. This expansion during the forecast period is driven by factors such as the growth of personalized medicine and biomarker-based testing, a growing move towards decentralized healthcare services, the increasing use of AI-powered diagnostic systems, an increase in home-based healthcare monitoring, and more regulatory approvals for rapid diagnostic tools. Key trends for this period encompass the development of decentralized point-of-care diagnostic networks, a greater embrace of multiplex immunoassay platforms, the incorporation of wireless connectivity into portable analyzers, the expansion of cartridge-based rapid testing solutions, and a growing need for at-home immunodiagnostic options.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=43725572&type=smp
Point Of Care (POC) Immunoassay Analyzer Expansion Market Growth Momentum: Which Factors Are Influencing Demand?
The rising occurrence of infectious diseases is projected to drive the expansion of the point of care immunoassay analyser expansion market. These conditions are caused by pathogenic microorganisms, including bacteria, viruses, parasites, or fungi, which spread directly or indirectly among individuals. The increased prevalence of infectious diseases is fueled by higher global population density, which accelerates transmission risks and disease dissemination. Point of care (POC) immunoassay analyzers expansion aids in addressing infectious diseases by enabling swift, accurate, and decentralized identification of infectious biomarkers, thereby enhancing early diagnosis and disease control initiatives. For instance, in March 2025, the UK Health Security Agency reported that tuberculosis cases in England saw a 13% increase in 2024, totaling 5,480 cases compared to 4,850 cases in 2023. Therefore, the growing prevalence of infectious diseases acts as a key driver for the point of care immunoassay analyser expansion market.
Point Of Care (POC) Immunoassay Analyzer Expansion Market Segment Analysis And Revenue Opportunities
The point of care (poc) immunoassay analyzer expansion market covered in this report is segmented –
1) By Product Type: Portable Analyzers, Benchtop Analyzers, Microfluidic Analyzers
2) By Technology: Chemiluminescence, Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay
3) By Sample Type: Blood, Urine, Saliva
4) By Application: Infectious Diseases, Hormonal Testing, Autoimmune Disorders, Cardiac Markers, Oncology
5) By End User: Hospitals, Diagnostic Laboratories, Home Care Settings, Academic Research Institutions
Subsegments:
1) By Portable Analyzers: Handheld Immunoassay Analyzers, Battery Operated Diagnostic Analyzers, Wireless Connected Portable Analyzers, Single Test Portable Analyzers, Multi Test Portable Analyzers
2) By Benchtop Analyzers: Compact Laboratory Benchtop Analyzers, High Throughput Benchtop Analyzers, Fully Automated Benchtop Analyzers, Semi Automated Benchtop Analyzers, Multi Assay Benchtop Systems
3) By Microfluidic Analyzers: Lab On A Chip Analyzers, Cartridge Based Microfluidic Analyzers, Continuous Flow Microfluidic Systems, Droplet Based Microfluidic Analyzers, Integrated Microfluidic Diagnostic Systems
Point Of Care (POC) Immunoassay Analyzer Expansion Market Trends Reshaping Industry Growth
Key companies within the point of care immunoassay analyser expansion market are prioritizing the creation of innovative solutions, including enhancements in immunoassay technologies, to address the increasing need for prompt diagnostics, distributed healthcare, and immediate clinical decision-making in urgent and remote environments. These sophisticated immunoassay analyzers represent compact diagnostic platforms that employ antigen–antibody reactions to identify biomarkers with significant sensitivity, providing advantages like swift processing, portability, reduced sample preparation, and multi-target testing functionalities. In contrast to conventional centralized laboratory analyzers, which necessitate complex infrastructure and extended processing durations, POC systems facilitate testing close to the patient, leading to quicker outcomes and enhanced accessibility. As an illustration, in July 2023, the China-based diagnostics firm Anbio Biotechnology introduced its AF-100S Fluorescence Immunoassay Analyzer. This system functions as a compact, automated fluorescent immunoassay analyzer specifically engineered for the rapid quantitative identification of biomarkers within clinical samples like whole blood, serum, and plasma. It incorporates fluorescence-based detection technology alongside automated calibration and integrated quality control, guaranteeing high sensitivity and accuracy that rivals centralized laboratory systems. Moreover, the analyzer boasts an intuitive interface and provides test results within minutes, rendering it exceptionally well-suited for emergency departments, clinics, and decentralized healthcare environments.
Point Of Care (POC) Immunoassay Analyzer Expansion Market Leading Players Shaping Industry Direction
Major companies operating in the point of care (poc) immunoassay analyzer expansion market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Becton, Dickinson and Company (BD), Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen N. V., Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc., Zeesan Biotech Co. Ltd.
Access The Complete Point Of Care (POC) Immunoassay Analyzer Expansion Market Report:
Point Of Care (POC) Immunoassay Analyzer Expansion Market Largest Region By Revenue And Market Share
North America was the largest region in the point-of-care immunoassay analyzer expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care (POC) immunoassay analyzer expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.